Anhui Expressway (995 HK/600012 CH)



Similar documents
Inner Mongolia Yili ( CH)

abc Global Research 361 Degrees (1361) Company visit

Thailand GDP (Q1 2016)

Yuhan Corp ( KS)

Argentina s national accounts revision Lower growth forecast, no clarity on GDP warrants yet

Minsheng Bank (1988 HK/ CH)

abc Global Research Saudi Telecom Company (STC AB) Flashnote Upgrade to OW: Fixed broadband powering revenue growth Overweight

Thailand Economics and FX

abc Wind Acquisitions Refinancing and trade ideas Recommendation Global Research Flashnote Refinancing options and trade ideas

BDI BioEnergy Intern Neutral. Activity level in Q3 might not support FY estimates

Summary fact sheet. Must be able to settle internationally, such as via Euroclear. Minimum of one year remaining to maturity

Tough Quarters Ahead, Downgrade to Reduce

Flexituff International Ltd. (FIL)

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

Satisfactory Top-Line; Disappointing Bottom-Line

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

Samsung Life Insurance KS. Company report. Buy. Buy: Solid insurance profit plus strong protection sales

Exhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)

Private drilling fluid technology service leader

Bright Smart (1428 HK)

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

Lojas Americanas (LAME4 BZ)

Coal India Ltd. Subdued e-auction realization impacted profitability BUY. Nov. 17, 2015

Oracle Corp. (ORCL) Sounds like we should forget about move to subscription accounting. The Goldman Sachs Group, Inc.

Sinopec Oilfield Services (1033 HK/ CH)

Update on HKEx Equity Derivatives Market. Derivatives Trading Global Markets Division 24 April 2015

E 2013E 2014E

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

Hong Kong. abc. *Employed by a non-us affiliate of HSBC Securities (USA) Inc, and is not registered/qualified pursuant to FINRA regulations

Gujarat State Petronet Ltd. INR 135

Company Overview. Financial Performance

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

1H15 Results Review: Table-1: Chanjet s Income Statement Analysis RMB (Thousand) 1H15 1H14 YoY Comments -Sale of software 170, ,278 0.

Longfor (960 HK) Unrated Real Estate Development Industry

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

MATELAN Research. Intelligent Transportation Systems MEGATRENDS DRIVE MARKET GROWTH FINANCIALS ACCELERATING IVU AND INIT SHOW HIGHEST UPSIDES

Renminbi Depreciation and the Hong Kong Economy

Cemex LatAm Holdings. Equity Research. 3Q15: Another disappointing quarter. BTG Pactual Global Research

Company Report. New China Life (1336 HK) Hold Life & Health Insurance Industry 2013E target price: HK$34.30 (from HK$24.

Petrel Energy Ltd. This report is intended for Unauthorized redistribution of this report is prohibited.

HCC BUY. Infrastructure January 29, 2016

GlaxoSmithKline Consumer Healthcare

Background information. Changes in the shareholder structure and balance sheet. Contract with Google prolonged for two years

Korea Internet. Telecoms, Media & Technology Korea Internet. Mobile payments. 21 August 2015

Year-end Dec 2013A 2014E 2015E 2016E Key data. # Priced at market close, 29/09/14

Copel. Equity Research. Weak Q1 results. BTG Pactual Global Research. Latin America Electric & Other Utilities Company Note 13 May 2016

Tupras OUTPERFORM (M) 15 February Strong 2009 results on refining side...

potential of business still not fully exploited; PT raised to Q results vs. estimates IFRS Q3 15 Q2 15 qoq Q3 14 yoy Q3 15e delta

SOHO China (410) Buy Nov 20, Company update. 4 Acquisitions within 6 Months. Samson Man, CFA (852) samson.man@firstshanghai.com.

Walmex. Equity Research. 4Q15 A miss, no signs of operating leverage. BTG Pactual Global Research

Halk REIT. Bloomberg: HLGYO TI OUTPERFORM. Reuters: HLGYO IS. An overlooked REIC with a premium portfolio

Bata India Ltd. (BIL)

GAIL (India) Ltd. INR 346

Britannia Industries

G5 Entertainment. G5 Entertainment. Quarter Update Q3 15. Amended strategy and boosted profitability

DO WE NEED MORE STORAGE IN EUROPE?

Navin Fluorine International

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

The Ramco Cements. Source: Company Data; PL Research

China Property Sector Expecting lower policy risk due to stabilizing home prices

Debt to Grow at a Slower Pace Lowering Target Price but Reiterating Buy

SK Networks ( KS)

Leading enterprise in domestic TFT liquid crystal material market

GEFRAN. 1Q16 results in line. Buy (maintained) Company report. 13 May Electrical equipment

HSBC Holdings plc and HSBC Bank Canada Presentation to Fixed Income Investors. September 2013

BUY. Muted Q3; Brands & Retail story to unfold ARVIND. Target Price: Rs 344. Segmental highlights

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

Global Markets Research COMMONWEALTH PROGRAMS. BUSINESS AS USUAL SCENARIO (% of GDP) UNDERLYING BUDGET BALANCE (% of GDP)

HOLD. The case of missing sales growth ZYDUS WELLNESS. Target Price: Rs 780. Q3highlights

Highlights of 1H FY2015 Results. November 18, 2015

SOHO CHINA (410.HK) At the Key Phase of Business Transformation. Neutral (Update) HONG KONG PROPERTY COMPANY UPDATE.

Empresaria (EMR.L) Empressive finish to the year

Quant Picks United Breweries

Company Report. Ping An (2318 HK) Sell Life & Health Insurance Industry 2013E target price: HK$68.46 (from HK$58.04 previously)

Khambatta Securities Ltd.

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Ituran Location & Control Ltd. In-line Quarter, Big Dividend, Maintain Outperform

Transcription:

Company report Industrials Equity China 995 HK Hold Target price (HKD) 7.00 Share price (HKD) 6.90 Upside/Downside (%) +1.4% Year to 12/14 a 12/15 e 12/16 e HSBC EPS (CNY) 0.51 0.56 0.58 PE (HSBC) 11.0 10.1 9.7 Performance 1M 3M 12M Absolute (%) 5.3-6.8 44.1 Relative (%)* -0.8 3.1 39.3 * HSCEI 600012 CH Reduce Target price (CNY) 5.90 Share price (CNY) 13.02 Upside/Downside (%) -54.7% Year to 12/14 a 12/15 e 12/16 e PE (HSBC) 25.3 23.3 22.4 Performance 1M 3M 12M Absolute (%) 39.7 8.3 152.8 Relative (%)* 27.0 26.0 73.5 * CSI 300 Index Wei Sim* The HongKong and Shanghai Banking Corporation Limited +852 2996 6602 weisim@hsbc.com.hk Shubhi Bansal* Associate Bangalore View HSBC Global Research at: http://www.research.hsbc.com *Employed by a non-us affiliate of HSBC Securities (USA) Inc, and is not registered/qualified pursuant to FINRA regulations Issuer of report: The HongKong and Shanghai Banking Corporation Limited Disclaimer & Disclosures This report must be read with the disclosures and the analyst certifications in the Disclosure appendix, and with the Disclaimer, which forms part of it Anhui Expressway (995 HK/600012 CH) H: Hold/ A: Reduce: Vitals are steady Toll revenue up 5.4% y-o-y in Jul-Sep period vs. our 2H estimate of 3.9% y-o-y After negative growth in 2Q, revenue growth on Hening turned positive in 3Q Maintain Hold rating on H share with a TP of HKD7.0 and Reduce rating on A share with a TP of RMB5.9 Jul-Sep consolidated revenue is up 5.4% y-o-y, 1.6ppt ahead of our 2H15 estimate: Volume growth is tracking 6.3ppt ahead of our estimate, at 11.7% y-o-y. Volume growth across all the eight roads is tracking either in line or ahead of our estimates, as shown in the table below. Hening Expressway, which was dragging the growth down in 2Q15, turned positive in 3Q15. Being the single largest contributor to the company s revenue, its performance plays a significant role. We maintain our Hold rating on the H share with a TP of HKD7.0 (implied upside of 1.4%) and Reduce rating on the A share with a TP of RMB5.9 (implied downside of 54.7%). Our target prices are DCF based. Anhui Expressway volume and revenue growth vs. HSBC estimates Hening GaoJie XuanGuang LianHuo NingHuai NH205 Guangci XuanNing Total FY15e revenue contri 45.3% 23.0% 11.6% 10.6% 4.8% 2.3% 1.9% 0.6% 100.0% HTD vol YoY 3.4% 14.5% 11.2% 16.9% 13.0% 9.5% 13.0% 54.8% 11.7% HSBC 1H15 est 3.5% 5.9% 5.9% 5.9% 5.9% 5.9% 5.9% 11.1% 5.4% A vs. E -0.1% 8.7% 5.3% 11.0% 7.1% 3.6% 7.2% 43.7% 6.3% HTD rev YoY 1.3% 9.1% 7.0% 4.6% 3.5% 18.6% 8.2% 65.7% 5.4% HSBC 1H15 est 0.9% 5.9% 6.9% 6.1% 0.6% 2.7% 8.5% 16.7% 3.9% A vs. E 0.4% 3.3% 0.1% -1.5% 3.0% 15.9% -0.3% 49.0% 1.6% HTD ARPV YoY -2.0% -4.7% -3.7% -10.5% -8.4% 8.3% -4.2% 7.0% -5.7% HSBC 1H15 est -2.5% 0.0% 1.0% 0.3% -5.0% -3.0% 2.5% 5.0% -1.5% A vs. E 0.5% -4.7% -4.7% -10.7% -3.4% 11.3% -6.7% 2.0% -4.2% estimates, Company data YueXiu Transport Infra (1052 HK, HKD5.24, Buy, TP HKD8.2) remains our preferred pick in the China Expressways sector. RIC 0995.HK / 600012.SS Market cap (USDm) 2,829 Free Float 995 HK 30 % Market cap (HKDm) 21,926 Free Float 600012 CH 100 % Market cap (CNYm) 17,963 THIS CONTENT MAY NOT BE DISTRIBUTED IN THE PEOPLE'S REPUBLIC OF CHINA (THE "PRC") (EXCLUDING SPECIAL ADMINISTRATIVE REGIONS OF HONG KONG AND MACAO)

Financials & valuation Financial statements Year to 12/2014a 12/2015e 12/2016e 12/2017e Profit & loss summary (CNYm) Revenue 3,037 3,114 3,676 3,520 EBITDA 1,944 1,904 1,972 1,966 Depreciation & amortisation -628-630 -630-630 Operating profit/ebit 1,316 1,274 1,342 1,336 Net interest -173-57 -49-49 PBT 1,160 1,234 1,309 1,303 HSBC PBT 1,160 1,234 1,309 1,303 Taxation -301-286 -323-322 Net profit 852 926 965 960 HSBC net profit 852 926 965 960 Cash flow summary (CNYm) Cash flow from operations 651 1,194 874 880 Capex -773-751 -1,273-1,063 Cash flow from investment 828-533 -986-776 Dividends -365-381 -402-419 Change in net debt -1,364-523 449 261 FCF equity -444 163-705 -499 Balance sheet summary (CNYm) Intangible fixed assets 9,222 9,001 8,714 8,427 Tangible fixed assets 1,208 1,677 2,998 4,110 Current assets 756 1,151 700 438 Cash & others 463 809 361 100 Total assets 11,631 12,268 12,852 13,414 Operating liabilities 1,805 2,171 2,171 2,171 Gross debt 1,294 1,117 1,117 1,117 Net debt 831 308 757 1,018 Shareholders' funds 7,684 8,191 8,753 9,294 Invested capital 8,919 8,849 9,881 10,704 Ratio, growth and per share analysis Year to 12/2014a 12/2015e 12/2016e 12/2017e Y-o-y % change Revenue -9.3 2.6 18.1-4.2 EBITDA 4.0-2.1 3.5-0.3 Operating profit 3.7-3.2 5.3-0.4 PBT 1.8 6.4 6.2-0.5 HSBC EPS 9.0 8.6 4.2-0.5 Ratios (%) Revenue/IC (x) 0.3 0.4 0.4 0.3 ROIC 10.4 11.0 10.8 9.8 ROE 11.5 11.7 11.4 10.6 ROA 8.2 8.3 8.1 7.8 EBITDA margin 64.0 61.1 53.6 55.8 Operating profit margin 43.3 40.9 36.5 37.9 EBITDA/net interest (x) 11.3 33.5 40.6 40.5 Net debt/equity 9.7 3.4 7.9 10.1 Net debt/ebitda (x) 0.4 0.2 0.4 0.5 CF from operations/net debt 78.4 387.6 115.5 86.4 Per share data (CNY) EPS reported (diluted) 0.51 0.56 0.58 0.58 HSBC EPS (diluted) 0.51 0.56 0.58 0.58 DPS 0.23 0.24 0.25 0.25 Book value 4.63 4.94 5.28 5.60 Valuation data: 995 HK Year to 12/2014a 12/2015e 12/2016e 12/2017e EV/sales 6.0 5.7 5.0 5.3 EV/EBITDA 9.4 9.4 9.3 9.4 EV/IC 2.1 2.0 1.9 1.7 PE* 11.0 10.1 9.7 9.8 PB 1.2 1.1 1.1 1.0 FCF yield (%) -2.5 0.9-4.0-2.8 Dividend yield (%) 4.1 4.3 4.5 4.5 * Based on HSBC EPS (diluted) Valuation data: 600012 CH Year to 12/2014a 12/2015e 12/2016e 12/2017e EV/sales 6.0 5.7 5.0 5.3 EV/EBITDA 9.4 9.4 9.3 9.4 EV/IC 2.1 2.0 1.9 1.7 PE* 25.3 23.3 22.4 22.5 PB 2.8 2.6 2.5 2.3 FCF yield (%) -2.5 0.9-4.0-2.8 Dividend yield (%) 1.8 1.9 1.9 1.9 * Based on HSBC EPS (diluted) Price relative: 995 HK 10.60 9.60 8.60 7.60 6.60 5.60 4.60 3.60 2.60 2.60 2013 2014 2015 2016 Anhui Expressway Rel to HSCEI Price relative: 600012 CH 21.20 16.20 11.20 6.20 Note: Priced at close of 20 Oct 2015 10.60 9.60 8.60 7.60 6.60 5.60 4.60 3.60 21.20 16.20 11.20 6.20 1.20 1.20 2013 2014 2015 2016 Anhui Expressway A Rel to CSI 300 Index 2

Historical traffic volume and toll revenue and ARPV trends Anhui historical YoY traffic volume growth Vol YoY Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Hening 1.2% -1.1% -1.4% -0.4% 1.3% -4.5% -11.0% -8.4% -1.6% 0.9% 0.9% 22.1% 8.0% -2.1% -1.8% -0.1% 3.4% 7.0% GaoJie 25.0% 20.2% 17.4% 22.3% 32.4% 28.5% 20.7% -7.5% 1.8% 1.9% 1.9% 39.6% 11.5% 4.2% 10.4% 16.7% 13.1% 13.8% XuanGuang 6.4% 3.0% 0.7% 3.1% 10.5% 4.7% 2.4% 1.4% 6.4% -13.0% -13.0% 46.5% 7.3% 3.0% 10.3% 10.1% 11.7% 11.5% LianHuo 14.8% 11.8% 6.6% 10.8% 12.1% 1.9% 1.3% 5.3% 8.1% -7.5% -7.5% 28.7% 8.9% 4.0% 6.9% 8.6% 18.7% 23.7% NingHuai 15.1% 17.0% 10.1% 12.7% 7.5% 8.6% 7.7% 6.3% 11.9% 16.5% 16.5% 13.6% 7.3% 5.0% 8.5% 9.4% 19.4% 10.2% NH205-12.1% -0.7% -14.1% -12.0% -17.5% -16.8% -14.4% -15.4% -15.8% -1.7% -1.7% -7.3% 8.7% 3.7% 8.3% 8.1% 12.2% 8.2% Guangci 8.3% 0.9% -0.6% 2.6% 11.2% 5.2% 1.6% 0.9% 6.3% -13.1% -13.1% 52.3% 9.0% 5.2% 11.9% 12.1% 13.7% 13.2% XuanNing - - - - - 287.9% 184.5% 167.9% 154.7% 69.2% 69.2% 92.3% 83.4% 65.6% 65.6% 59.4% 57.0% 48.7% Total 8.9% 7.2% 3.4% 6.1% 8.1% 5.3% 2.1% 0.1% 5.3% -1.1% -1.1% 29.8% 9.4% 3.9% 7.9% 9.2% 13.7% 12.3% Source: Company data Anhui historical YoY toll revenue growth Rev YoY Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Hening -8.4% -7.1% -11.7% -11.0% -10.2% -14.7% -17.6% -14.3% -8.7% 2.6% 2.6% 7.9% 5.0% -5.4% -6.3% -3.8% 3.0% 4.9% GaoJie 43.8% 46.8% 41.3% 42.5% 56.6% 55.0% 38.1% -4.9% -7.5% 10.2% 10.2% 16.1% 8.7% 3.9% 4.0% 12.6% 7.6% 7.4% XuanGuang -3.8% 0.3% -2.8% -3.7% 1.9% -0.6% -1.7% -1.9% 1.7% -1.1% -1.1% 25.2% 3.5% 0.0% 3.7% 3.1% 8.6% 9.1% LianHuo 8.2% 18.4% 3.6% 3.5% 3.2% -4.6% 0.2% 5.5% 6.5% 5.4% 5.4% 9.6% 0.2% -9.6% -6.4% -2.8% 7.6% 9.1% NingHuai 18.1% 13.0% 6.5% 9.9% 5.3% 1.7% 1.2% 0.5% 1.6% 5.0% 5.0% 3.4% 1.2% -3.0% -2.2% -1.2% 8.9% 2.9% NH205-11.3% -7.8% -11.8% -14.2% -20.8% -18.8% -15.6% -16.9% -16.1% -4.1% -4.1% -15.7% 11.8% 11.5% 11.5% 13.9% 21.0% 20.8% Guangci -5.0% -5.6% -7.1% -4.3% 6.1% 2.2% -2.6% -1.6% 2.9% -1.4% -1.4% 32.4% 6.4% 3.2% 5.9% 5.1% 10.2% 9.3% XuanNing - - - - - 270.6% 186.5% 174.7% 212.2% 125.4% 125.4% 105.2% 100.0% 80.1% 76.1% 71.5% 68.4% 58.1% Total 2.8% 5.5% -0.0% 0.2% 3.6% 0.2% -2.9% -7.2% -4.2% 3.9% 3.9% 13.2% 5.6% -1.7% -0.9% 2.0% 6.8% 7.4% Source: Company data Anhui historical YoY ARPV growth ARPV YoY Apr-14 May-14 Jun-14 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Hening -9.5% -6.0% -10.4% -10.6% -11.4% -10.7% -7.4% -6.5% -7.2% 3.1% 3.1% -11.7% -2.8% -3.3% -4.5% -3.7% -0.4% -2.0% GaoJie 15.1% 22.1% 20.4% 16.5% 18.3% 20.7% 14.5% 2.8% -9.2% 13.4% 13.4% -16.9% -2.5% -0.3% -5.8% -3.5% -4.8% -5.6% XuanGuang -9.6% -2.6% -3.5% -6.6% -7.8% -5.1% -4.0% -3.3% -4.4% 14.7% 14.7% -14.5% -3.5% -2.9% -6.0% -6.4% -2.8% -2.2% LianHuo -5.7% 5.9% -2.8% -6.6% -7.9% -6.4% -1.1% 0.2% -1.5% 13.8% 13.8% -14.9% -8.0% -13.1% -12.5% -10.5% -9.3% -11.8% NingHuai 2.6% -3.4% -3.3% -2.4% -2.1% -6.4% -6.1% -5.4% -9.2% -4.5% -4.5% -8.9% -5.7% -7.6% -9.9% -9.7% -8.8% -6.7% NH205 0.9% -7.2% 2.6% -2.5% -4.0% -2.4% -1.4% -1.7% -0.4% -4.0% -4.0% -9.1% 2.8% 7.5% 2.9% 5.3% 7.9% 11.7% Guangci -12.3% -6.5% -6.6% -6.7% -4.6% -2.9% -4.1% -2.5% -3.2% 14.3% 14.3% -13.1% -2.4% -1.9% -5.3% -6.3% -3.1% -3.4% XuanNing - - - - - -4.5% 0.7% 2.5% 22.5% 26.2% 26.2% 6.7% 9.0% 8.7% 6.4% 7.6% 7.3% 6.3% Total -5.6% -1.5% -3.3% -5.6% -4.2% -4.9% -5.0% -7.2% -9.1% 5.1% 5.1% -12.8% -3.4% -5.4% -8.2% -6.5% -6.1% -4.4% Source: Company data Valuation and risks Anhui Expressway (995 HK, Hold, CMP HKD6.9, TP HKD7.0)/(600012 CH, Reduce, CMP RMB13.02, TP RMB5.9) We value the H-share at HKD7.0 and the A-share at RMB5.9 based on a DCF methodology. Our DCF valuation for the H-share is derived from the RMB-denominated cash flows whereby future cash flows (in RMB) are discounted and converted based on the HSBC FX team s exchange rate forecasts of 1.20 in FY15 and 1.18 in FY16 and beyond. We incorporate a 7.5% WACC, which itself is based on a 3.5% risk free rate, a 5.5% equity risk premium, a 0.8x beta, a cost of debt of 5.0% and a tax rate of 25.0%. Our A share DCF target price is derived directly from the RMB denominated cash flows of the company. We maintain a Hold rating on the H-share with an implied upside of 1.4% and a Reduce rating on the A- share with an implied downside of 54.7%. 3

Upside risks for A-share and H-share: Stronger-than-forecast traffic volume growth or value-accretive asset injections from the parent company. Downside risks for the H-share: Deterioration in freight to passenger vehicle traffic due to a slowdown in the economy leading to lower-than-forecast ARPV. The company has higher sensitivity to this being based in central China, where the freight to passenger ratio in vehicles is higher than peers. YueXiu Transport Infra (1052 HK, CMP HKD5.24, Buy, TP HKD8.2) We have a fair value target price for YueXiu Transport Infra at HKD8.2. This is based on a DCF valuation methodology, incorporating a WACC of 7.5%, which itself is based on a risk-free rate of 3.5%, an equity risk premium of 5.5%, a beta of 1.2x, a cost of debt of 5.9%, and an effective tax rate of 32.4%. We maintain our Buy rating on the stock with an implied upside of 56.5%. Downside risks: Slower-than-forecast growth of new roads or the company s toll road portfolio overall. There has been a higher-than-forecast negative impact on the Qinglian Expressway from the diversion of traffic to the recently-opened Guangle Expressway. To the extent that if traffic volumes on Qinglian further deteriorates, there is downside risk to our traffic growth forecasts for 2015. Depreciation of the RMB would also result in exchange losses for the company. 4

China Expressways valuation comparison table China Expressways: Valuation comparison table Company Ticker Rating Last Price* 1M chg (%) 3M chg (%) YTD chg (%) TP (lcy) Up/Dn side (%) Mkt Cap (USD m) 6M T/O PER EV/EBITDA P/B ROE (%) Yield (%) Net D/E (%) EPS growth (%) _ (USD m) FY15E FY16E FY17E FY15E FY16E FY17E FY15E FY16E FY17E FY15E FY16E FY17E FY15E FY16E FY17E FY15E FY16E FY17E FY15E FY16E FY17E Sichuan (H) 107 HK Hold 2.76 7.0-8.3-15.6 2.70-2.2 2,359 2.42 8.2 8.1 7.7 11.8 10.2 8.7 0.6 0.5 0.5 7.2 6.8 6.8 3.0 3.0 3.1 99 85 71-13 0 6 Jiangsu (H) 177 HK Hold 10.12 0.2 1.3 10.8 10.10-0.2 6,677 4.69 15.2 13.4 13.2 8.7 7.8 7.3 2.0 1.9 1.8 13.0 14.4 14.0 5.4 5.5 5.7 50 40 30 7 13 1 Shenzhen (H) 548 HK Buy 5.97 14.1 1.4 17.1 6.00 0.5 2,211 3.15 10.8 10.5 11.3 6.8 6.9 0.6 0.9 0.8 0.6 8.3 8.3 6.1 3.7 3.9 3.5 41 39-23 2 3-8 Zhejiang 576 HK Buy 9.34 9.8-3.7 1.4 10.70 14.6 5,324 10.21 11.7 10.1 9.7 5.2 4.1 3.6 1.8 1.7 1.5 16.0 17.1 16.5 5.1 5.5 5.8 5-6 -16 21 16 5 Hopewell 737 HK Hold 3.93 3.4 3.4 1.6 4.00 1.8 1,571 0.94 19.1 18.3 15.0 8.7 8.7 7.6 1.4 1.5 1.5 7.2 7.8 9.8 10.8 5.3 6.5 69 67 60-6 4 22 Anhui (H) 995 HK Hold 6.90 5.3-6.8 33.7 7.00 1.4 3,172 2.55 10.1 9.7 9.8 9.4 9.3 9.4 1.1 1.1 1.0 11.7 11.4 10.6 4.3 4.5 4.5 3 8 10 9 4-0 Yuexiu 1052 HK Buy 5.24 6.9-2.6 11.7 8.20 56.5 1,099 1.16 10.2 9.9 9.7 7.8 5.8 5.3 0.8 0.8 0.8 8.2 8.2 8.1 5.4 6.1 6.1 70 59 49 10 4 1 Sichuan (A) 601107 CH Reduce 4.85 9.7-14.8-10.5 2.40-50.5 2,359 45.76 17.5 17.5 16.5 11.8 10.2 8.7 1.2 1.2 1.1 7.2 6.8 6.8 1.4 1.4 1.5 99 85 71-13 0 6 Jiangsu (A) 600377 CH Hold 8.44 8.8 4.1 18.9 8.60 1.9 6,677 30.00 15.4 13.6 13.5 8.7 7.8 7.3 2.0 1.9 1.9 13.0 14.4 14.0 5.3 5.5 5.6 50 40 30 7 13 1 Shenzhen (A) 600548 CH Reduce 6.48 9.8-22.8-19.9 5.00-22.8 2,211 24.20 14.3 13.8 15.0 6.8 6.9 0.6 1.2 1.1 0.8 8.3 8.3 6.1 2.8 2.9 2.6 41 39-23 2 3-8 Anhui (A) 600012 CH Reduce 13.02 39.7 8.3 112.4 5.90-54.7 3,172 45.70 23.3 22.4 22.5 9.4 9.3 9.4 3.1 3.0 2.9 11.7 11.4 10.6 3.5 3.5 3.6 3 8 10 9 4-0 Huabei (A) 000916 CH NR 5.78 13.8-14.6 13.3 978 35.61 18.9 15.9 14.5 n/a n/a n/a 1.4 1.3 n/a 8.4 9.7 n/a 1.8 2.2 n/a n/a n/a n/a 46 19 10 Fujian (A) 600033 CH NR 4.06 6.6-16.6 6.6 1,763 84.30 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a Shandong (A) 600350 CH NR 6.73 16.6-13.3 36.0 5,195 55.96 12.5 11.0 9.9 6.1 n/a n/a 1.4 1.3 1.1 11.8 12.3 11.6 2.3 2.3 1.5 n/a n/a n/a 1 14 11 Jilin (A) 601518 CH NR 4.84 13.9-16.3 30.5 938 52.46 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a CMHP CMH SP NR 0.93 2.2-8.8 0.1 787 0.84 9.9 9.8 9.0 23.7 20.2 18.2 0.7 0.9 0.8 9.0 8.6 9.2 7.2 7.5 8.3 n/a n/a n/a - 1 8 H share average 5.8-2.1 9.1 12.5 11.4 11.1 8.0 7.3 6.1 1.5 1.4 1.3 11.8 12.4 12.0 5.1 5.0 5.1 39 32 19 7 9 3 A share average 15.2-6.8 28.1 16.2 14.9 14.5 8.3 8.4 7.0 1.8 1.7 1.6 11.1 11.7 11.1 3.4 3.5 3.3 46 40 24 5 10 3 Sector average 10.6-4.5 18.7 14.3 13.1 12.7 8.1 7.7 6.5 1.6 1.5 1.4 11.5 12.1 11.6 4.3 4.2 4.3 42 35 21 6 9 3 Anhui Expressway (995 HK/600012 CH) *Last Price updated on 20 October 2015 close Sector averages are market cap weighted Source: Thomson Reuters Datastream, HSBC estimates 5

Disclosure appendix Certification The following analyst(s), economist(s), and/or strategist(s) who is(are) primarily responsible for this report, certifies(y) that the opinion(s) on the subject security(ies) or issuer(s) and/or any other views or forecasts expressed herein accurately reflect their personal view(s) and that no part of their compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report: Wei Sim Equities: Stock ratings and basis for financial analysis HSBC believes an investor's decision to buy or sell a stock should depend on individual circumstances such as the investor's existing holdings, risk tolerance and other considerations and that investors utilise various disciplines and investment horizons when making investment decisions. Ratings should not be used or relied on in isolation as investment advice. Different securities firms use a variety of ratings terms as well as different rating systems to describe their recommendations and therefore investors should carefully read the definitions of the ratings used in each research report. Further, investors should carefully read the entire research report and not infer its contents from the rating because research reports contain more complete information concerning the analysts' views and the basis for the rating. From 23rd March 2015 HSBC has assigned ratings on the following basis: The target price is based on the analyst s assessment of the stock s actual current value, although we expect it to take six to 12 months for the market price to reflect this. When the target price is more than 20% above the current share price, the stock will be classified as a Buy; when it is between 5% and 20% above the current share price, the stock may be classified as a Buy or a Hold; when it is between 5% below and 5% above the current share price, the stock will be classified as a Hold; when it is between 5% and 20% below the current share price, the stock may be classified as a Hold or a Reduce; and when it is more than 20% below the current share price, the stock will be classified as a Reduce. Our ratings are re-calibrated against these bands at the time of any 'material change' (initiation or resumption of coverage, change in target price or estimates). Upside/Downside is the percentage difference between the target price and the share price. Prior to this date, HSBC s rating structure was applied on the following basis: For each stock we set a required rate of return calculated from the cost of equity for that stock s domestic or, as appropriate, regional market established by our strategy team. The target price for a stock represented the value the analyst expected the stock to reach over our performance horizon. The performance horizon was 12 months. For a stock to be classified as Overweight, the potential return, which equals the percentage difference between the current share price and the target price, including the forecast dividend yield when indicated, had to exceed the required return by at least 5 percentage points over the succeeding 12 months (or 10 percentage points for a stock classified as Volatile*). For a stock to be classified as Underweight, the stock was expected to underperform its required return by at least 5 percentage points over the succeeding 12 months (or 10 percentage points for a stock classified as Volatile*). Stocks between these bands were classified as Neutral. *A stock was classified as volatile if its historical volatility had exceeded 40%, if the stock had been listed for less than 12 months (unless it was in an industry or sector where volatility is low) or if the analyst expected significant volatility. However, stocks which we did not consider volatile may in fact also have behaved in such a way. Historical volatility was defined as the past month's average of the daily 365-day moving average volatilities. In order to avoid misleadingly frequent changes in rating, however, volatility had to move 2.5 percentage points past the 40% benchmark in either direction for a stock's status to change. 6

As of, the distribution of all ratings published is as follows: Buy 46% (31% of these provided with Investment Banking Services) Hold 40% (29% of these provided with Investment Banking Services) Sell 14% (17% of these provided with Investment Banking Services) For the purposes of the distribution above the following mapping structure is used during the transition from the previous to current rating models: under our previous model, Overweight = Buy, Neutral = Hold and Underweight = Sell; under our current model Buy = Buy, Hold = Hold and Reduce = Sell. For rating definitions under both models, please see Stock ratings and basis for financial analysis above. Share price and rating changes for long-term investment opportunities YueXiu Transport Infrastr (1052.HK) Share Price performance HKD Vs HSBC rating history 9 8 7 6 5 4 3 2 1 Anhui Expressway A (600012.SS) Share Price performance CNY Vs HSBC rating history 21 19 17 15 13 11 9 7 5 3 Oct-10 Oct-10 Oct-11 Oct-11 Oct-12 Oct-12 Oct-13 Oct-13 Oct-14 Oct-14 Oct-15 Oct-15 Recommendation & price target history From To Date Overweight Neutral 26 February 2013 Neutral Overweight 04 July 2013 Overweight Neutral 05 August 2014 Neutral Underweight 01 December 2014 Underweight Overweight 21 January 2015 Overweight Buy 07 April 2015 Target Price Value Date Price 1 4.80 26 February 2013 Price 2 4.70 18 March 2013 Price 3 4.90 04 July 2013 Price 4 5.10 15 August 2013 Price 5 5.90 04 March 2014 Price 6 6.00 19 March 2014 Price 7 6.10 27 March 2014 Price 8 5.30 07 May 2014 Price 9 5.10 26 August 2014 Price 10 4.90 01 December 2014 Price 11 6.30 21 January 2015 Price 12 6.00 18 March 2015 Price 13 7.60 07 May 2015 Price 14 7.70 31 July 2015 Price 15 8.20 13 August 2015 Recommendation & price target history From To Date N/A Underweight 03 March 2015 Underweight Reduce 25 March 2015 Target Price Value Date Price 1 4.00 03 March 2015 Price 2 4.10 25 March 2015 Price 3 4.90 31 March 2015 Price 4 5.50 07 May 2015 Price 5 6.10 05 June 2015 Price 6 5.80 31 July 2015 Price 7 5.90 24 August 2015 7

Anhui Expressway (0995.HK) Share Price performance HKD Vs HSBC rating history 10 9 8 7 6 5 4 3 2 Oct-10 HSBC & disclosures Disclosure checklist Recommendation & price target history From To Date Overweight Neutral 26 February 2013 Neutral Overweight 26 March 2013 Overweight Neutral 04 July 2013 Neutral Underweight 07 May 2014 Underweight Hold 25 March 2015 Hold Buy 31 March 2015 Buy Hold 07 April 2015 Target Price Value Date Price 1 4.90 26 February 2013 Price 2 4.80 26 March 2013 Price 3 4.10 04 July 2013 Price 4 4.20 26 August 2013 Price 5 4.90 03 March 2015 Price 6 5.00 25 March 2015 Price 7 6.00 31 March 2015 Price 8 6.80 07 May 2015 Price 9 7.50 05 June 2015 Price 10 7.30 31 July 2015 Price 11 7.00 24 August 2015 Company Ticker Recent price Price Date Disclosure ANHUI EXPRESSWAY 0995.HK 6.90 20-Oct-2015 1, 2, 4, 5, 6, 7 ANHUI EXPRESSWAY A 600012.SS 13.02 20-Oct-2015 1, 2, 4, 5, 6, 7 YUEXIU TRANSPORT INFRASTRUCTUR 1052.HK 5.24 20-Oct-2015 1, 4, 5 Oct-11 Oct-12 Oct-13 Oct-14 Oct-15 1 HSBC has managed or co-managed a public offering of securities for this company within the past 12 months. 2 HSBC expects to receive or intends to seek compensation for investment banking services from this company in the next 3 months. 3 At the time of publication of this report, HSBC Securities (USA) Inc. is a Market Maker in securities issued by this company. 4 As of 30 September 2015 HSBC beneficially owned 1% or more of a class of common equity securities of this company. 5 As of 31 August 2015, this company was a client of HSBC or had during the preceding 12 month period been a client of and/or paid compensation to HSBC in respect of investment banking services. 6 As of 31 August 2015, this company was a client of HSBC or had during the preceding 12 month period been a client of and/or paid compensation to HSBC in respect of non-investment banking securities-related services. 7 As of 31 August 2015, this company was a client of HSBC or had during the preceding 12 month period been a client of and/or paid compensation to HSBC in respect of non-securities services. 8 A covering analyst/s has received compensation from this company in the past 12 months. 9 A covering analyst/s or a member of his/her household has a financial interest in the securities of this company, as detailed below. 10 A covering analyst/s or a member of his/her household is an officer, director or supervisory board member of this company, as detailed below. 11 At the time of publication of this report, HSBC is a non-us Market Maker in securities issued by this company and/or in securities in respect of this company HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments (including derivatives) of companies covered in HSBC Research on a principal or agency basis. s, economists, and strategists are paid in part by reference to the profitability of HSBC which includes investment banking revenues. Whether, or in what time frame, an update of this analysis will be published is not determined in advance. 8

For disclosures in respect of any company mentioned in this report, please see the most recently published report on that company available at www.hsbcnet.com/research. Additional disclosures 1 This report is dated as at. 2 All market data included in this report are dated as at close 20 October 2015, unless otherwise indicated in the report. 3 HSBC has procedures in place to identify and manage any potential conflicts of interest that arise in connection with its Research business. HSBC's analysts and its other staff who are involved in the preparation and dissemination of Research operate and have a management reporting line independent of HSBC's Investment Banking business. Information Barrier procedures are in place between the Investment Banking and Research businesses to ensure that any confidential and/or price sensitive information is handled in an appropriate manner. 9

Disclaimer * Legal entities as at 30 May 2014 UAE HSBC Bank Middle East Limited, Dubai; HK The Hongkong and Shanghai Banking Corporation Limited, Hong Kong; TW HSBC Securities (Taiwan) Corporation Limited; 'CA' HSBC Bank Canada, Toronto; HSBC Bank, Paris Branch; HSBC France; DE HSBC Trinkaus & Burkhardt AG, Düsseldorf; 000 HSBC Bank (RR), Moscow; IN HSBC Securities and Capital Markets (India) Private Limited, Mumbai; JP HSBC Securities (Japan) Limited, Tokyo; EG HSBC Securities Egypt SAE, Cairo; CN HSBC Investment Bank Asia Limited, Beijing Representative Office; The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch; The Hongkong and Shanghai Banking Corporation Limited, Seoul Securities Branch; The Hongkong and Shanghai Banking Corporation Limited, Seoul Branch; HSBC Securities (South Africa) (Pty) Ltd, Johannesburg; HSBC Bank plc, London, Madrid, Milan, Stockholm, Tel Aviv; US HSBC Securities (USA) Inc, New York; HSBC Yatirim Menkul Degerler AS, Istanbul; HSBC México, SA, Institución de Banca Múltiple, Grupo Financiero HSBC; HSBC Bank Brasil SA Banco Múltiplo; HSBC Bank Australia Limited; HSBC Bank Argentina SA; HSBC Saudi Arabia Limited; The Hongkong and Shanghai Banking Corporation Limited, New Zealand Branch incorporated in Hong Kong SAR; The Hongkong and Shanghai Banking Corporation Limited, Bangkok Branch Issuer of report The Hongkong and Shanghai Banking Corporation Limited Level 19, 1 Queen s Road Central Hong Kong SAR Telephone: +852 2843 9111 Fax: +852 2596 0200 Website: www.research.hsbc.com This document has been issued by The Hongkong and Shanghai Banking Corporation Limited ( HSBC ) in the conduct of its Hong Kong regulated business for the information of its institutional and professional investor (as defined by Securities and Future Ordinance (Chapter 571)) customers; it is not intended for and should not be distributed to retail customers in Hong Kong. The Hongkong and Shanghai Banking Corporation Limited is regulated by the Hong Kong Monetary Authority. All enquires by recipients in Hong Kong must be directed to your HSBC contact in Hong Kong. If it is received by a customer of an affiliate of HSBC, its provision to the recipient is subject to the terms of business in place between the recipient and such affiliate. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. HSBC has based this document on information obtained from sources it believes to be reliable but which it has not independently verified; HSBC makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the Research Division of HSBC only and are subject to change without notice. HSBC and its affiliates and/or their officers, directors and employees may have positions in any securities mentioned in this document (or in any related investment) and may from time to time add to or dispose of any such securities (or investment). HSBC and its affiliates may act as market maker or have assumed an underwriting commitment in the securities of companies discussed in this document (or in related investments), may sell them to or buy them from customers on a principal basis and may also perform or seek to perform investment banking or underwriting services for or relating to those companies. HSBC Securities (USA) Inc. accepts responsibility for the content of this research report prepared by its non-us foreign affiliate. All U.S. persons receiving and/or accessing this report and wishing to effect transactions in any security discussed herein should do so with HSBC Securities (USA) Inc. in the United States and not with its non-us foreign affiliate, the issuer of this report. In the UK this report may only be distributed to persons of a kind described in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. The protections afforded by the UK regulatory regime are available only to those dealing with a representative of HSBC Bank plc in the UK. In Singapore, this publication is distributed by The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch for the general information of institutional investors or other persons specified in Sections 274 and 304 of the Securities and Futures Act (Chapter 289) ( SFA ) and accredited investors and other persons in accordance with the conditions specified in Sections 275 and 305 of the SFA. This publication is not a prospectus as defined in the SFA. It may not be further distributed in whole or in part for any purpose. The Hongkong and Shanghai Banking Corporation Limited Singapore Branch is regulated by the Monetary Authority of Singapore. Recipients in Singapore should contact a "Hongkong and Shanghai Banking Corporation Limited, Singapore Branch" representative in respect of any matters arising from, or in connection with this report. In Australia, this publication has been distributed by The Hongkong and Shanghai Banking Corporation Limited (ABN 65 117 925 970, AFSL 301737) for the general information of its wholesale customers (as defined in the Corporations Act 2001). Where distributed to retail customers, this research is distributed by HSBC Bank Australia Limited (AFSL No. 232595). These respective entities make no representations that the products or services mentioned in this document are available to persons in Australia or are necessarily suitable for any particular person or appropriate in accordance with local law. No consideration has been given to the particular investment objectives, financial situation or particular needs of any recipient. This publication is distributed in New Zealand by The Hongkong and Shanghai Banking Corporation Limited, New Zealand Branch incorporated in Hong Kong SAR. In Japan, this publication has been distributed by HSBC Securities (Japan) Limited. It may not be further distributed in whole or in part for any purpose. In Korea, this publication is distributed by The Hongkong and Shanghai Banking Corporation Limited, Seoul Securities Branch ("HBAP SLS") for the general information of professional investors specified in Article 9 of the Financial Investment Services and Capital Markets Act ( FSCMA ). This publication is not a prospectus as defined in the FSCMA. It may not be further distributed in whole or in part for any purpose. HBAP SLS is regulated by the Financial Services Commission and the Financial Supervisory Service of Korea. In Canada, this document has been distributed by HSBC Bank Canada and/or its affiliates. Where this document contains market updates/overviews, or similar materials (collectively deemed Commentary in Canada although other affiliate jurisdictions may term Commentary as either macro-research or research ), the Commentary is not an offer to sell, or a solicitation of an offer to sell or subscribe for, any financial product or instrument (including, without limitation, any currencies, securities, commodities or other financial instruments). Copyright 2015, The Hongkong and Shanghai Banking Corporation Limited, ALL RIGHTS RESERVED. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, on any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of The Hongkong and Shanghai Banking Corporation Limited. MICA (P) 073/06/2015, MICA (P) 136/02/2015 and MICA (P) 041/01/2015 10

Global Industrials Research Team Industrials Colin Gibson Global Sector Head, Industrials +44 20 7991 6592 colin.gibson@hsbcib.com Scott Cagehin +44 20 7992 1444 scott.cagehin@hsbc.com Brian Cho Head of Research, Korea +822 3706 8750 briancho@kr.hsbc.com Paul Choi +822 3706 8758 paulchoi@kr.hsbc.com Anderson Chow +852 2996 6669 andersonchow@hsbc.com.hk Puneet Gulati +91 22 2268 1235 puneetgulati@hsbc.co.in Michael Hagmann +44 20 7991 2405 michael.hagmann@hsbcib.com Yeon Lee +822 3706 8778 yeonlee@kr.hsbc.com Kristy Lee +65 6658 0616 kristy.zx.lee@hsbc.com.sg Sean McLoughlin +44 20 7991 3464 sean.mcloughlin@hsbcib.com Ashutosh Narkar +91 22 2268 1474 ashutoshnarkar@hsbc.co.in Shrinidhi Karlekar +91 22 6164 0689 shrinidhi.karlekar@hsbc.co.in Mark Webb +852 2996 6574 markwebb@hsbc.com.hk Nick Webster '+27 11 676 4537 nick.webster@za.hsbc.com Thomas Zhu, CFA +852 2822 4325 thomasjzhu@hsbc.com.hk Autos Horst Schneider +49 211 910 3285 horst.schneider@hsbc.de Yogesh Aggarwal +91 22 2268 1246 yogeshaggarwal@hsbc.co.in Henning Cosman +49 211 910 2461 henning.cosman@hsbc.de Vivek Gedda +91 22 6164 0693 vivekgedda@hsbc.co.in Carson Ng +852 2822 4397 carsonksng@hsbc.com.hk Mike Yip Associate +852 2996 6942 mike.h.y.yip@hsbc.com.hk Transportation Andrew Lobbenberg +44 20 7991 6816 andrew.lobbenberg@hsbcib.com Aric Hui Associate +852 2822 3165 ariccshui@hsbc.com.hk Parash Jain +852 2996 6717 parashjain@hsbc.com.hk Achal Kumar +91 80 3001 3722 achalkumar@hsbc.co.in Wei Sim +852 2996 6602 weisim@hsbc.com.hk Shishir Singh +852 2822 4292 shishirkumarsingh@hsbc.com.hk Jack Xu +852 2996 6566 jack.y.xu@hsbc.com.hk Joe Thomas +44 20 7992 3618 joe.thomas@hsbcib.com Construction & Engineering Levent Bayar +90 212 376 46 17 leventbayar@hsbc.com.tr Tarun Bhatnagar +65 6658 0614 tarunbhatnagar@hsbc.com.sg Pierre Bosset Head of French Research +33 1 56 52 43 10 pierre.bosset@hsbc.com Jonathan Brandt +1 212 525 4499 jonathan.l.brandt@us.hsbc.com Ivan Enriquez +52 55 5721 2397 ivan.enriquez@hsbc.com.mx John Fraser-Andrews +44 20 7991 6732 john.fraser-andrews@hsbcib.com Tobias Loskamp +49 211 910 2828 tobias.loskamp@hsbc.de Lesley Liu +852 2822 4524 lesleylliu@hsbc.com.hk Shishir Singh +852 2822 4292 shishirkumarsingh@hsbc.com.hk Patrick Gaffney, CFA +966 11 299 2100 patrickgaffney@hsbc.com Nicholas Paton, CFA +971 4 423 6923 nicholas.paton@hsbc.com Sean Tian +852 2996 6916 sean.x.tian@hsbc.com.hk Liwei Zhou +852 2996 6743 liwei.zhou@hsbc.com.hk Emily Li +852 2996 6599 emily.c.li@hsbc.com.hk Specialist Sales Rod Turnbull +44 20 7991 5363 rod.turnbull@hsbcib.com Oliver Magis +49 21 1910 4402 oliver.magis@hsbc.de Billal Ismail +44 20 7991 5362 billal.ismail@hsbcib.com Jean Gael Tabet +44 20 7991 5342 jeangael.tabet@hsbcib.com